Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Merck
Johnson and Johnson
McKinsey
Healthtrust
Julphar
Harvard Business School
Deloitte
US Army
Chubb

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 071945

« Back to Dashboard

NDA 071945 describes MAPROTILINE HYDROCHLORIDE, which is a drug marketed by Am Therap, Mylan, Watson Labs, and Watson Labs Teva, and is included in ten NDAs. It is available from one supplier. Additional details are available on the MAPROTILINE HYDROCHLORIDE profile page.

The generic ingredient in MAPROTILINE HYDROCHLORIDE is maprotiline hydrochloride. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the maprotiline hydrochloride profile page.
Summary for 071945
Tradename:MAPROTILINE HYDROCHLORIDE
Applicant:Watson Labs
Ingredient:maprotiline hydrochloride
Patents:0
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 071945

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength75MG
Approval Date:Dec 30, 1987TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Mallinckrodt
AstraZeneca
Colorcon
Cipla
Johnson and Johnson
Teva
Queensland Health
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot